← Back to all stories
Targeted Immune Cell Therapy Eradicates Aggressive Childhood Brain Tumors in Preclinical Study

Photo: Bhautik Patel / Unsplash
Researchers at UC San Francisco have engineered a novel CAR-T cell therapy that safely activates only inside the brain to target deadly tumors. In preclinical trials, the treatment successfully eliminated diffuse midline glioma—a historically fatal pediatric cancer—in every model tested.
Researchers at UC San Francisco have engineered a novel CAR-T cell therapy that safely activates only inside the brain to target deadly tumors. In preclinical trials, the treatment successfully eliminated diffuse midline glioma—a historically fatal pediatric cancer—in every model tested.